Miller Fisher Syndrome in Patients With Severe Acute Respiratory Syndrome Coronavirus 2 Infection: A Systematic Review
Синдром Миллера—Фишера у пациентов с инфекцией, вызванной коронавирусом 2, вызывающим тяжелый острый респираторный синдром: систематический обзор
2021-01-01
SCID: 54.1/44cynrmh
Discuss with AI
Guillain-Barré syndromeMiller Fisher syndromeSARS-CoV-2 infectionantiganglioside antibodiesintravenous immunoglobulin
Figures from the paper
Abstract (AI)
BACKGROUND AND PURPOSE: Miller Fisher syndrome (MFS) is a subtype of Guillain-Barré syndrome characterized by the triad of ophthalmoparesis, areflexia, and ataxia. Although cases of MFS have been associated with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, no studies have synthesized the clinical characteristics of patients with this condition. METHODS: In this rapid systematic review, we searched the PubMed database to identify studies on MFS associated with SARS-CoV-2 infection. RESULTS: This review identified 11 cases, of whom 3 were hospitalized with motor and/or sensory polyneuropathy as the first sign of SARS-CoV-2 infection. SARS-CoV-2 RNA was not detected in analyses of cerebrospinal fluid, suggesting a mechanism of immune-mediated injury rather than direct viral neurotropism. However, antiganglioside antibodies were found in only two of the nine patients tested. It is possible that target antigens other than gangliosides are involved in MFS associated with SARS-CoV-2 infection. CONCLUSIONS: The present patients exhibited clinical improvement after being treated with intravenous immunoglobulin. Although rare, patients with SARS-CoV-2 infection may present neurological symptoms suggestive of MFS. Early recognition of the MFS clinical triad is essential for the timely initiation of treatment.
Key Findings
1
A rapid systematic review identified 11 reported cases of Miller Fisher syndrome associated with SARS-CoV-2 infection.
2
Antiganglioside antibodies were detected in only two of nine tested patients, suggesting that other target antigens may contribute to SARS-CoV-2-associated Miller Fisher syndrome.
3
Patients clinically improved after intravenous immunoglobulin treatment, emphasizing the importance of early recognition of the characteristic clinical triad.
4
SARS-CoV-2 RNA was absent from cerebrospinal fluid, supporting immune-mediated injury rather than direct viral neurotropism.
5
Three patients were hospitalized with motor and/or sensory polyneuropathy as the first manifestation of SARS-CoV-2 infection.
Research Object
Miller Fisher syndrome associated with SARS-CoV-2 infection
Research Subject
Clinical characteristics, immune-mediated pathogenesis, and treatment response of Miller Fisher syndrome associated with SARS-CoV-2 infection
Publication Details
Publication Date
2021-01-01
Journal
Publisher
ISSN
Cited by
21
Open access PDF
Access Type
Author Information
Download PDF
Subscribe to digest